This plateau is likely due to reduced diagnostic activity in the very elderly, including fewer prostate-specific antigen (PSA) tests, less frequent biopsy referrals, and declining incidental detection from TURP (transurethral resection of the prostate), as medical management of benign prostatic hypertrophy has become more common [2]. Here, KLK3 is linked to benign prostatic hyperplasia.